Four-Pronged attack on stubborn blood cancer tested
NCT ID NCT03590652
Summary
This study tested a combination of four medications for people with multiple myeloma that has come back or stopped responding to prior treatments. The goal was to see how well the combination worked and how safe it was. The trial was stopped early and enrolled 23 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
-
University of California, Davis
Sacramento, California, 95817, United States
-
University of California, Los Angeles
Los Angeles, California, 90024, United States
-
University of California, San Francisco
San Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.